It Seems Organigram Holdings Inc Will Go Down. Have Big Gap Down Today

 It Seems Organigram Holdings Inc Will Go Down. Have Big Gap Down Today

The stock of Organigram Holdings Inc (CVE:OGI) gapped down by $0.18 today and has $2.29 target or 9.00% below today’s $2.52 share price. The 6 months technical chart setup indicates high risk for the $265.40 million company. The gap down was reported on Nov, 22 by Barchart.com. If the $2.29 price target is reached, the company will be worth $23.89 million less.
Gaps down are helpful for identifying a resistance level and to could also be used as a tradeable event. If traders are short the stock and it experiece gap down, then its usually advisable to hold the short for a bigger down move. Back-tests of such patterns show that two-thirds of the these patterns the stock performance worsens after the gap. The area gaps close 91% of the time, the breakaway gaps 1%, the continuation gaps 9% and the exhaustion gaps 64%. About 3.00M shares traded hands. Organigram Holdings Inc (CVE:OGI) has risen 6.00% since October 23, 2016 and is uptrending. It has outperformed by 1.44% the S&P500.

More notable recent Organigram Holdings Inc (CVE:OGI) news were published by: Profitconfidential.com which released: “Organigram Holdings Inc: OGI Stock Rally Hinges on This” on November 21, 2016, also Marketwatch.com with their article: “OrganiGram Holdings Inc. Announces Issuance of Stock Options” published on June 28, 2016, Marketwired.com published: “OrganiGram Holdings Inc. Announces No Material Change” on November 14, 2016. More interesting news about Organigram Holdings Inc (CVE:OGI) were released by: Marketwired.com and their article: “OrganiGram Holdings Announces $35 Million Bought Deal” published on November 15, 2016 as well as Marketwired.com‘s news article titled: “OrganiGram Holdings Inc. Receives License to Sell Oil Extracts” with publication date: June 22, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment